MedTech Terms
    The authoritative reference
    Back to Manufacturing & Supply Chain
    ManufacturingManufacturing & Supply

    Lot Traceability

    Ability to trace materials, processes, and devices forward and backward through the supply chain by lot number.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    21 CFR 820.65 requires traceability for devices intended for surgical implant or whose failure could cause significant injury. Lot traceability links UDI-PI to inputs, processes, and finished-goods distribution records. Under the QMSR, traceability follows ISO 13485 clause 7.5.9, with extra requirements for implantable devices including records of components, materials and work environment conditions. Good traceability lets a company scope a recall to specific lots. The EU MDR also requires distributors and health institutions to store UDIs for certain implantable devices.
    What the regulation says
    Regulators emphasize lot traceability as a cornerstone of post-market surveillance and quality assurance. For instance, the FDA's 21 CFR 820.65 mandates specific traceability requirements for certain high-risk devices, enabling rapid identification and removal of defective products from the market. Similarly, the EU MDR (Regulation (EU) 2017/745) Annex I, General Safety and Performance Requirements, stresses the importance of traceability for all devices to ensure patient safety and facilitate effective market surveillance. ISO 13485:2016, clause 7.5.9, also requires organizations to establish requirements for traceability.

    What this means in practice

    Effective traceability is the difference between scoping a recall to a few lots versus the entire installed base.

    Examples

    • A manufacturer identifies a defect in a specific batch of raw material used in an implantable device; lot traceability allows them to pinpoint all affected finished devices and initiate a targeted recall.
    • During a post-market surveillance review, an increase in adverse event reports is linked to devices from a particular manufacturing lot, prompting an investigation and potential field safety corrective action.
    • An auditor requests to see the complete manufacturing history, including all components and process steps, for a specific lot of medical instruments, which is provided through detailed traceability records.
    Common pitfalls
    • •Failing to link all unique device identification, production identifiers (UDI-PI) to their corresponding manufacturing records and raw material lots is a common mistake.
    • •Inadequate documentation of each stage of the manufacturing process, from raw materials to final distribution, can severely hamper traceability efforts during an audit or recall.
    • •Lax control over third-party logistics and distribution partners can create gaps in the traceability chain.
    • •Not regularly testing or auditing the traceability system through mock recalls is a critical oversight.
    • •Relying solely on paper-based systems without adequate backups or digital integration can lead to data loss and inefficiencies.

    Frequently asked questions

    The primary purpose is to enable rapid identification and isolation of specific device lots in the event of quality issues, recalls, or adverse events. It ensures patient safety by minimizing the scope and impact of potential product failures.

    Related terms

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Learning paths (1)

    Latest in MedTech

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 2Tier 2Regulator guidance and consensus· 1
    Link health: 3 verified· last checked 2026-06-20
    eCFR·1ISO·1IMDRF/GHTF·1
    1. 1
      21 CFR 820.65
      Tier 1 Verified
      eCFRecfr.gov
    2. 2
      ISO 13485 Standard Page
      Tier 1 Verified
      ISOiso.org
    3. 3
      GHTF/IMDRF Process Validation Guidance
      Tier 2 Verified
      IMDRF/GHTFimdrf.org

    Inline markers like [1] jump to the matching reference above.